ARBs, by inhibiting the angiotensin II type 1 receptor, reduce blood pressure, but also reduce inflammation, improve endothelial function, and decrease oxidative stress, all of which could indirectly impact the mechanisms involved in the onset of dementia [64]. The gene discussed is AGTR1; the disease is dementia.